The move is part of a broader push to onshore pharmaceutical production and reduce reliance on foreign suppliers, particularly from India and China.
Glenmark's Acamprosate Calcium delayed release tablets are a generic version of Forest Labs' Campral. The drug had sales of USD 21 million for 12-months ended March 2013, according to IMS Health data.
Pharmaceutical company Unichem Laboratories has received abbreviated new drug approval (ANDA) from US Food and Drugs Administration for a copy of Tizanidine tablets, used as a muscle relaxant. The news sent its shares up over 2 percent in afternoon trade.